We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASZ
226
DELISTED
Austerlitz Acquisition Corporation II
ASZ
| $50.3M | 0.1% |
5,144,032
| – | – |
|
|
PSTH
227
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $49.9M | 0.09% |
2,508,389
+90,911
| +4% | +$1.8M |
|
|
JWSM
228
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
| $49.7M | 0.09% |
5,070,415
| – | – |
|
229
Moody's
MCO
$81.7B
| $49.6M | 0.09% |
147,061
-27,813
| -16% | -$9.35M |
|
|
CVII
230
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $49.4M | 0.09% |
5,046,108
| – | – |
|
231
Alexandria Real Estate Equities
ARE
$8.88B
| $49.1M | 0.09% |
244,094
+216,294
| +778% | +$42.2M |
|
232
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $49.1M | 0.09% |
502,319
+318,204
| +173% | +$32.2M |
|
233
Charles River Laboratories
CRL
$10.9B
| $49.1M | 0.09% |
172,859
-281,936
| -62% | -$86.9M |
|
234
Roku
ROKU
$21.1B
| $48.8M | 0.09% |
389,341
+221,542
| +132% | +$32.5M |
|
|
AAC
235
DELISTED
Ares Acquisition Corporation
AAC
| $48.8M | 0.09% |
4,970,350
| – | – |
|
236
Equity Lifestyle Properties
ELS
$12.8B
| $48.7M | 0.09% |
636,941
+335,488
| +111% | +$25.9M |
|
237
Fortinet
FTNT
$112B
| $48M | 0.09% |
702,140
+540,380
| +334% | +$33.6M |
|
238
CALL
Netflix
NFLX
$292B
| $47.8M | 0.09% |
1,275,000
+787,000
| +161% | +$32.8M |
|
239
Consolidated Edison
ED
$41.6B
| $47.7M | 0.09% |
503,343
+261,049
| +108% | +$22.6M |
|
240
SAP
SAP
$187B
| $47.6M | 0.09% |
429,230
-78,533
| -15% | -$9.55M |
|
|
MPT
241
Medical Properties Trust
MPT
$2.89B
| $47.4M | 0.09% |
2,243,827
+1,067,046
| +91% | +$23M |
|
242
Zoom
ZM
$25.8B
| $47.4M | 0.09% |
+404,539
| New | +$55M |
|
243
Spotify
SPOT
$99.2B
| $47M | 0.09% |
311,319
-358,570
| -54% | -$61.2M |
|
244
Xenon Pharmaceuticals
XENE
$6.32B
| $46.9M | 0.09% |
1,534,058
+313,101
| +26% | +$9.37M |
|
245
Air Products & Chemicals
APD
$66.3B
| $46.8M | 0.09% |
187,266
+168,126
| +878% | +$43.2M |
|
246
Walt Disney
DIS
$165B
| $46.7M | 0.09% |
340,738
+337,722
| +11,198% | +$48.8M |
|
247
CALL
Apple
AAPL
$4.89T
| $46.7M | 0.09% |
267,200
+5,700
| +2% | +$959K |
|
248
Motorola Solutions
MSI
$69.4B
| $46.6M | 0.09% |
192,434
+32,570
| +20% | +$7.57M |
|
|
APLS
249
DELISTED
Apellis Pharmaceuticals
APLS
| $46.5M | 0.09% |
+915,163
| New | +$40.4M |
|
|
PLAN
250
DELISTED
Anaplan, Inc.
PLAN
| $46.3M | 0.09% |
711,108
+190,989
| +37% | +$9.3M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.